A network aimed at understanding and treating cancer cachexia.
The CANcer Cachexia Action Network (CANCAN):a Multidisciplinary Virtual Institutewith the Mission to Cure Cancer CachexiaCANCAN - BEATSON
This study is looking into cancer cachexia, a tough condition that causes weight loss and muscle loss in many cancer patients, to find out how it works and discover new treatments that could help improve patients' health and quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beatson Institute for Cancer Research NIH-funded |
| Lab location | 1 site (Glasgow, United Kingdom) |
| Project ID | NIH-10625047 on NIH RePORTER |
What this research studies
This research focuses on cancer cachexia, a serious condition affecting around 80% of cancer patients, characterized by significant weight loss and muscle wasting. The project brings together a diverse group of international experts to explore the underlying mechanisms of cachexia and identify potential treatments. By utilizing advanced techniques to study the interactions between tumors and the body's metabolism, the research aims to uncover new insights that could lead to effective therapies. Patients may benefit from improved treatment responses and enhanced quality of life if successful.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients experiencing symptoms of cachexia, such as significant weight loss and muscle wasting.
Not a fit: Patients who do not have cancer or those who are not experiencing cachexia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments for cancer cachexia, improving patient outcomes and survival rates.
How similar studies have performed: While there has been extensive research on cancer cachexia, this multidisciplinary approach is relatively novel and aims to fill critical gaps in understanding and treatment.
Where this research is happening
Glasgow, United Kingdom
- Beatson Institute for Cancer Research — Glasgow, United Kingdom (Active)
Researchers
- Principal investigator: Lewis, David Y — Beatson Institute for Cancer Research
- Study coordinator: Lewis, David Y
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.